Charles River Laboratories’ Post

🌟 Advanced Therapies Week Highlight: Launch of Charles River's Global Biotech Incubator Program 🌟 Join Kerstin Dolph, Senior VP of Manufacturing at Charles River Laboratories, and host Benjamin McLeod from Convey Bio for an exciting introduction to the Charles River Incubator Program (CIP). This pioneering program supports the journey of early-stage biotechnology companies in the development of advanced therapies. The CIP is dedicated to nurturing startups by offering regulatory guidance, quality expertise, personnel training, and access to laboratory facilities, all aimed at enhancing their path to commercial success. Discover how your biotech venture can apply and benefit from this unique opportunity to accelerate growth and innovation. #AdvancedTherapiesWeek #ATW25 #AdvancedTherapies #CharlesRiver #BiotechIncubator

Shared lab spaces are a great way to reduce costs and accelerate progress for biotech start-ups. These spaces provide a streamlined launchpad complete with benches and a diverse network of industry mentors. If you're interested in learning more about co-working labs and how they can benefit your biotech start-up, check out the link below. #biotech #coworkinglabs

🚀 Charles River Launches Biotech Incubator Program 🧫Charles River Laboratories unveils a biotech incubator program to foster innovation and accelerate early-stage research breakthroughs. Know complete story: https://lnkd.in/d3u3AHXk #PharmaNews #BiotechInnovation #ResearchDevelopment #HealthcareAdvancements #PharmaceuticalIndustry Dawn Joha Smitha Gawde, Ph.D.

🚀Biotechnology: The Engine Driving Medical Advancements🚀 What's the future of life science like, and what are the advantages of the MAxL incubator? In the latest edition of VentureCapital Magazin, Christian Gnam (IZB - Innovation and Start-up Center Biotechnology) and Ralf Huss (BioM Biotech Cluster Development GmbH) answer these questions and share insights on how #MAxL drives biotech advancements, enhances partnerships, and offers new opportunities in the biotech landscape.📈 📖 Find out more: https://lnkd.in/d6JwUvUc #Biotechnology #IZB #Startup #CampusMartinsried

Let Venture Capital Firms and NUVISAN Boost Your Drug Discovery Project! Are you working on an orphan disease drug discovery project or tackling challenging targets? This is your opportunity to collaborate with venture capitalists and scientific experts to propel your drug discovery initiative forward. The 2nd NUVISAN Innovation Challenge is seeking groundbreaking ideas in this space to accelerate the development of new treatments for patients in need. 🎯 Theme: Innovative Solutions for Orphan Diseases and Challenging Drug Targets 🎁 Prizes: Winners will have the opportunity to present their ideas to venture capitalists and receive expert scientific consultation from NUVISAN. 🌐 Who Can Apply: Companies worldwide working to address these unmet needs are encouraged to participate. 📅 Submission Deadline: October 29 Explore the event details here: https://lnkd.in/e7skKGDP We look forward to your application! #NUVISAN #ScienceCRO #InnovationChallenge #DrugDiscovery #OrphanDrugs #Biotech #VentureCapital

I found this video interesting. Who would of thought of Puerto Rico and biotech/life sciences entrepreneurship together. Check out this GEN webinar, sponsored by Invest Puerto Rico, where we will explore the latest innovations in biotech and how they are accelerating drug development in Puerto Rico. The expert panelists, included Rafael Perez, Senior Business Development Director for Invest Puerto Rico, and Jose Rodriguez-Orengo, Ph.D., CEO of MBQ Pharma. They are discussing the advantages of doing biotech in Puerto Rico. They will also shared insights on the latest biotech research and technology and how it is being used to accelerate drug development. Do not miss this opportunity to learn about the exciting advancements in biotech and how they are transforming the industry in Puerto Rico. https://lnkd.in/erVpjF_G

Explore how biotechs can unlock early value in their commercial journey and look ahead to a brighter future at the 2024 Fierce Biotech Summit. Don’t miss our presentation in the Strategy and Dealmaking track at 2:30pm on September 30. #commercialsuccess #biotech #innovation Karla Anderson, Maya K. Desai, PhD, Michele Fuller

#fundingalert 💼Company: PolarityTE 💰Funding: $22.5Million ⚡Round: New Round 👥Investors: Institutional investors and current shareholders PolarityTE, headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. It’s first regenerative tissue product is SkinTE®. PolarityTE has an open investigational new drug application (IND) for SkinTE® with the U.S. The credit agreement provides up to $10 million in total term loan capital including a first tranche of $5 million funded at closing. John Stetson, Jessica Shen, MD, MS, Arthur Telfeian Read more - https://lnkd.in/g7uH_rqU To share your startup story write us on - contact@startuprise.io #PolarityTE #biotechnology #biotechstartup #regenerativetissue #funding #fundingnews #news #startup #startupnews #startuprise

Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2024 of the Dutch life sciences sector. In 2022, the Dutch #biotech landscape saw a sharp 50% decline in venture #financing, reflecting the challenging global economic climate. 📢 Fortunately, the tide seems to turn. In 2023, life sciences saw a remarkable 50% rise in #funding, underscoring the sector’s resilience and growth potential. Headliners included VectorY, Tagworks Pharmaceuticals, Kynesis, Meatable, and VarmX. 🚀 Looking at this year’s benchmark of European biotech with those of the United States, US biotechs have three times as many #assets in clinical development per capita compared to their Dutch counterparts. The availability of funding in the US still far outranks funds in Europe, illustrating the stark contrast in financial ecosystems. 🚨 Check out the report: https://lnkd.in/e-p7UqfA

In the news! Find out what we had to say to Science|Business on our mission to ensure that 'Boosting Biotech & Biomanufacturing in the EU' is globally impactful for Europe. https://lnkd.in/eq_x3Jja